Difficulties and Countermeasures of Monitoring Adverse Drug Reactions in Primary Medical Institutions

© 2025 by the Authors. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )

Download PDF

Cite

XML

HTML

Abstract

Monitoring adverse drug reactions (ADRs) in primary medical institutions is crucial to ensuring medication safety. Currently, this work faces difficulties such as insufficient professional ability of staff, imperfect monitoring systems, and low patient awareness. It is necessary to improve the level of ADR monitoring at the grassroots level and ensure the safety and effectiveness of medication through countermeasures such as strengthening personnel training, optimizing monitoring processes, and raising public awareness.

References

Liu A, Li X, Ding S, et al., 2021, Analysis of Adverse Drug Reaction Reports From Primary Medical Institutions in Dongguan City From 2015 to 2019. Strait Pharmaceutical Journal, 33(11): 201–203.

Diao K, Lv H, 2021, Problems and Countermeasures of Adverse Drug Reaction Monitoring in Primary Medical Institutions. Popular Standardization, (13): 204–206.

Lin Q, Huang M, Chen R, 2021, Discussion on the Role of Medical Institutions in Adverse Drug Reaction Monitoring and Management. Chinese Medical Management Science, 11(01): 87–90.

Qi J, Yao X, Bai Y, 2020, Analysis of Influencing Factors Restricting Adverse Drug Reaction Monitoring in Medical Institutions and Discussion on Countermeasures. Electronic Journal of Clinical Medical Literature, 7(20): 176–182.

Li H, Du J, Zhang G, et al., 2021, Analysis of Adverse Drug Reactions in a Primary Medical Institution in a Remote and Poverty-Stricken Area Over Five Years. Chinese Community Doctors, 37(06): 10–11.

Previous article in this issue

Next article in this issue